PMID- 16471461 OWN - NLM STAT- MEDLINE DCOM- 20060413 LR - 20190827 IS - 0385-2407 (Print) IS - 0385-2407 (Linking) VI - 32 IP - 12 DP - 2005 Dec TI - Drug-induced hypersensitivity syndrome associated with human herpesvirus 6 and cytomegalovirus reactivation. PG - 976-81 AB - We describe a patient with drug-induced hypersensitivity syndrome (DIHS) associated with human herpesvirus 6 (HHV-6) and cytomegalovirus (CMV) infection induced by sulfasalazine. Two weeks after starting sulfasalazine to treat a rectal ulcer, the patient developed disseminated macular erythema accompanied by fever, liver injury, and lymphadenopathy. Seroconversion of antibodies to HHV-6 was observed. Systemic steroid treatment was not effective against the eruptions. Five months after the onset, he presented with an acute febrile disease. The detection of CMV antigen on peripheral blood leukocytes and positive staining for CMV on cutaneous endothelium indicated active CMV infection. Furthermore, he developed a bacteremia of methicillin resistant Staphylococcus aureus. An association the CMV reactivation with DIHS was suggested, although there remains the possibility that the systemic steroid treatment precipitated CMV reactivation. Recently, HHV-6 has been documented to have immunomodulating effects and to be associated with CMV reactivation. Therefore, we should pay attention to the possibility of CMV reactivation in patients with DIHS in whom the immunomodulating virus of HHV-6 has been reactivated. FAU - Komura, Kazuhiro AU - Komura K AD - Department of Dermatology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan. FAU - Hasegawa, Minoru AU - Hasegawa M FAU - Hamaguchi, Yasuhito AU - Hamaguchi Y FAU - Yukami, Toru AU - Yukami T FAU - Nagai, Masaki AU - Nagai M FAU - Yachie, Akihiro AU - Yachie A FAU - Sato, Shinichi AU - Sato S FAU - Takehara, Kazuhiko AU - Takehara K LA - eng PT - Case Reports PT - Journal Article PL - England TA - J Dermatol JT - The Journal of dermatology JID - 7600545 RN - 3XC8GUZ6CB (Sulfasalazine) SB - IM MH - Aged MH - Cytomegalovirus/physiology MH - Cytomegalovirus Infections/*diagnosis/pathology MH - Drug Hypersensitivity/*etiology/pathology MH - Exanthema Subitum/*chemically induced/pathology MH - Facial Dermatoses/chemically induced/pathology MH - Follow-Up Studies MH - Herpesvirus 6, Human/physiology MH - Humans MH - Male MH - Patch Tests MH - Risk Assessment MH - Severity of Illness Index MH - Sulfasalazine/*adverse effects/therapeutic use MH - Syndrome MH - *Virus Activation EDAT- 2006/02/14 09:00 MHDA- 2006/04/14 09:00 CRDT- 2006/02/14 09:00 PHST- 2005/05/11 00:00 [received] PHST- 2005/06/28 00:00 [accepted] PHST- 2006/02/14 09:00 [pubmed] PHST- 2006/04/14 09:00 [medline] PHST- 2006/02/14 09:00 [entrez] AID - 032120976 [pii] AID - 10.1111/j.1346-8138.2005.tb00885.x [doi] PST - ppublish SO - J Dermatol. 2005 Dec;32(12):976-81. doi: 10.1111/j.1346-8138.2005.tb00885.x.